PS

Paul Sagan

Catalyst Advisor at General Catalyst

Greater Boston

Overview 

Paul Sagan is currently a Catalyst Advisor at General Catalyst, with a background as a Managing Director and Executive in Residence at the same firm. He has served on the boards of various companies, including Bugcrowd and ProPublica, and has made investments in notable companies like Moderna and B12.

Work Experience 

  • Catalyst Advisor (Executive in Residence)

    2024 - Current

  • Sr. Advisor & Executive in Residence (XIR)

    2020 - 2024

  • Managing Director

    2018 - 2020

  • Executive in Residence (XIR)

    2014 - 2017

General Catalyst partners with ambitious founders to drive resilience and applied AI from seed to growth.

  • Board Member Nominee

    2025

  • Board Member

    2018

  • Board Chair

    2011

    Director Since 2011; Chairman 2017-present

  • Board Member

    2017

AirSlate is a SaaS technology that provides no-code business process automation, e-signature, and document management solutions.

Raised $181,500,000.00 from G Squared, UiPath Ventures, HighSage Ventures, Morgan Stanley Expansion Capital and General Catalyst.

  • Board Chair

    2024

Bugcrowd is a cybersecurity company that operates as a platform for crowdsourced security testing.

Raised $230,650,000.00 from Silicon Valley Bank.

  • Board Member

    2020

  • Board Member

    2020

  • Member, Board Of Trustees

    2021

Beth Israel Deaconess Medical Center is a health care system that brings together academic medical centers and teaching hospitals.

Raised $5,580,652.00 from Parkinson's Foundation, BIRD Foundation, MassAITC, Society to Improve Diagnosis in Medicine and Massachusetts Life Sciences Center.

Education 

Articles About Paul

Relevant Websites